Document Type : Article


1 Ph.D. Student in Public Law, Faculty of Law and Political Science, Allame tabataba’i, Tehran, Iran

2 Associate Prof. Department of Public and International Law, Faculty of Law and Political Science, Allame tabataba’i, Tehran, Iran


Regulating pharmaceutical advertisements, due to its effects on public safety and health, has highlighted the importance of government intervention and its regulatory methods in this sector. Regulating pharmaceutical advertising is very difficult because of the dynamic nature of the pharmaceutical industry, the distinction between prescription and non-prescription (over-the-counter) drugs, and the dual advertising environments, namely, public/ professional. Today, governments cooperate with other economic and social actors to regulate various sectors of the economy. However, in view of the direct relationship between health products and citizens' health, when it comes to such products, governments should exercise adequate supervision over the relevant regulatory bodies. Therefore, this paper will examine the task of the government to regulate pharmaceutical advertising. Then, with a qualitative method and a descriptive approach, the mechanisms by which different countries regulate pharmaceutical advertisements will be studied. We conclude that despite the availability of various regulatory methods, governments are trying to play a standard-setting role, even in self-regulatory systems, to monitor the industry in order to support the interests of pharmaceutical firms while also preserving public health.


  1. English

    A (Articles

    1. Azevedo, Jorge & colleagues-GlobalHealthPR (2013),” The Global Guide to Pharma Marketing Codes,GlobalHealthPR(Aurora),Vol.3, pp.1-173.
    2. Bennadi, Darshana (2014),” Self-medication: A current challenge”,Journal of Basic and Clinical Pharmacy,Vol.5, Issue.1.pp.19-23.
    3. Chepesiuk,Ray,(2005)“Standards for pharmaceutical advertising in Canada”, CMAJ&JAMC,Vol.173, No.3,publishonline:
    4. Donohue, Julie (2006),” A History of Drug Advertising: The Evolving Roles of Consumers and Consumer Protection”, the Milbank Quarterly,Vol.84, No.4, pp.659-699
    5. João Luis Vianna, Lívia Figueiredo and Anderson Ribeiro (2018)” Distribution and marketing of drugs in Brazil: overview”, ACC(Association of corporate counsel), pp.1-8, , publish online
    6. Lee Ventola.C, (2011),”Direct-to-Consumer Pharmaceutical Advertising/Therapeutic or Toxic?” P&TJournal(pharmacy and therapeutics),Vol.36, No.10, pp.669-684.
    7. Leonardo Alves, Teresa & Joel Lexchin, Barbara Mintzes (2018), “Medicines Information and the Regulation of the Promotion of Pharmaceuticals”, Springer: Science and Engineering Ethics,Vol.25, No.4, pp.1167-1192.
    8. Matheson, Alastair (2017), “Marketing trials, marketing tricks-how to spot them and how to stop them”,Journal trials,Vol.18, No.105, publish online:
    9. Praneeth. P (2016), “Regulatory Affairs and its Role in Pharmaceutical Industry”, International Journal of Pharmacy and Biomedical Engineering, Vol.3, Issue1. publish online:


    1. B) Documents
    2. Newsland medicines and medical devices safety authority, Guideline on the Regulation of Therapeutic Products in New Zealand, Part7: Advertising of therapeutic products, December 2019, pp.1-15.
    3. Un,convention on Psychotropic substances,1971.
    4. WTO, Declaration on the trips agreement and public health, 14 November 2001, WT/MIN(01)/DEC/2, NO.7.
    5. WHO, Approved by Medicine Advertisements Board(2015), Advertising of Medicines and Medicinal Products to General Public,Last date 25 January 2020,available in:


    1. C) Reports
    2. MHRA(Medicines and Healthcare products Regulatory Agency),(2019)” The Blue Guide-Advertising and Promotion of Medicines in the UK”, Advertising Standards and Outreach Unit,
    3. PricewaterhouseCoopers-PWC (2020),“Pharma 2020:Marketing the future/Which path will you take?”, pp.1-28.
    4. Ratanawijitrasin, Sauwakon, Wondemagegnehu, Eshetu (2002), “Effective drug regulation(A multicountry study), World Health Organization Pub(report):


    1. D) Website
    2. Chameleon pharma consulting: pharma regulatory, lastdate 26January 2020,available in:
    3. FDA: Prescription Drug Advertising: Questions and Answers,2015,Last date 30 November 2019 , available in:
    4. ICLG website, USA: Pharmaceutical Advertising 2019,available in:
    5. Preker, Alexander S.,10 July 2015, Welcome to the Health Industry, last date 8June 2020, available in:
    6. Chambers and partners, (Last Updated June 11,2019) Pharmaceutical Advertising(china), last date 28 January 2020, available in:


    References In Persian:

    1. A) Books
    2. The Holy Quran
    3. Abel-Smith, Brian (2010), The place of money in the health system (a treatise on health economics and medical sociology), translated by Abolghasem Pourreza, Tehran: Samat Publishing (In Persian).
    4. Bix, Brian (2010), A dictionary of legal theory, translated by Mohammad Rasekh, Tehran: Ney Publishing (In Persian).
    5. Senn, Myriam (2018), Market Regulation without Government Intervention (Recognition of Institutional Changes), translated by Seyed Alireza Shokoohian, Hamed Idrisian, Haidar Salami, Tehran: Majd Publishing (In Persian).


    1. B) Articles
    2. Borhani, Mohsen & Abuzari, Mehrnoosh (2017), " The Right to Medications along with Supporting Drug Innovations", Legal Journal of Justice, No. 99, pp. 11-30 (In Persian).
    3. Erfanmanesh, Mohammadhosein; Zahedi, Mahdi; Abbasi, Mahmood (2016), “Examination of Status and Challenges of Pharmaceutical Trademarks Registration in European”, Medical Law Journal, Vol.10, No. 36,, pp.127-150 (In Persian).
    4. Ghahremani Afshar, Newsha & Alizadeh Gholilo, Saeed (2015), "Investigation of Organized Crime with Emphasis on Drug Trafficking and Preventive Strategies", Quarterly Journal of Social Health & Addiction, Vol. 2, No.7, pp. 123-150 (In Persian).
    5. Imamian, Seyed Mohammad Sadegh; Zolfaghari, Amira Ahmad; Mohammadzadeh, Ehsan & Zamanian, Morteza (2018), "National system of regulation: 1. The concept of regulation and its relationship with the system of government ", Office of Economic Studies of the Public Sector, Deputy of Economic Research, Parliamentary Research Center, Subject Code 230, Serial Number 15940 (In Persian).
    6. Kasraie M; Moradkhani H; Rezaei M. (2012), “Foucault: Governmentality, Political Subject and Political Action”, MJSS journal, Vol. 3 , No.2, pp.1-34 (In Persian).
    7. Khandouzi, seyed Ehsan (2010), " Requirements of Regulatory State in the Iranian Economy", majlis & rahbord journal, No. 64, pp. 41-80 (In Persian).
    8. Sadeghi, Mohsen (2009), "The protection of pharmaceutical inventions and human rights challenges", Quarterly Journal of Private Law Studies, University of Tehran, Vol. 39, No. 3, pp. 193-215 (In Persian).
    9. Sedighi, Davood (2016), "Introduction to the indicators of postmodern government", Office of Basic Government Studies, Research Center of the Islamic Consultative Assembly, Subject Code 330, Serial Number 14869 (In Persian).
    10. Valizadeh, Hossein (2019), "Regulatory Analysis, Privatization in Iran", Qanuniyar Quarterly, Vol. 3, No. 11, pp. 255-298 (In Persian).
    11. Yavari, Asadollah (2014), " An introduction to concept of legal regulation", Journal of Comparative Law Studies, University of Tehran, Vol. 5 – No. 2, pp. 629-647 (In Persian).